Cargando…
Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients
Aberrant DNA methylation is a common epigenetic alteration involved in colorectal cancer (CRC). In our previous study, we performed methylated DNA immunoprecipitation-on-chip analysis combined with gene re-expression analysis by 5-aza-2′-deoxycytidine treatment, to identify methylation genes in CRC...
Autores principales: | Takane, Kiyoko, Midorikawa, Yutaka, Yagi, Koichi, Sakai, Ayako, Aburatani, Hiroyuki, Takayama, Tadatoshi, Kaneda, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302673/ https://www.ncbi.nlm.nih.gov/pubmed/24861485 http://dx.doi.org/10.1002/cam4.273 |
Ejemplares similares
-
DNA methylation epigenotype and clinical features of NRAS‐mutation(+) colorectal cancer
por: Takane, Kiyoko, et al.
Publicado: (2017) -
Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway
por: Sakai, Eiji, et al.
Publicado: (2015) -
Gastrointestinal stromal tumor with nephrotic syndrome as a paraneoplastic syndrome: a case report
por: Takane, Kiyoko, et al.
Publicado: (2014) -
Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation
por: Kikuchi, Yasuko, et al.
Publicado: (2013) -
Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis
por: Takane, Kiyoko, et al.
Publicado: (2016)